The economics of advanced and unresectable hepatocellular carcinoma

被引：0
|
作者：
Mattingly, T. Joseph, II [1 ]
Shetty, Kirti [2 ]
机构：
[1] Univ Maryland, Dept Pharmaceut Hlth Serv Res, Sch Pharm, 220 Arch St,12th Floor, Baltimore, MD 21201 USA
[2] Univ Maryland, Div Gastroenterol & Hepatol, Sch Med, Baltimore, MD USA
来源：
CANCER | 2022年 / 128卷 / 22期
关键词：
D O I：
10.1002/cncr.34456
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3907 / 3909
页数：3
相关论文
共 50 条
  • [1] Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
    Nicole L. France
    Hannah A. Blair
    [J]. Targeted Oncology, 2024, 19 : 115 - 123
  • [2] Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
    France, Nicole L.
    Blair, Hannah A.
    [J]. TARGETED ONCOLOGY, 2024, 19 (01) : 115 - 123
  • [3] Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinoma
    de Castria, Tiago Biachi
    Khalil, Danny N.
    Harding, James J.
    O'Reilly, Eileen M.
    Abou-Alfa, Ghassan K.
    [J]. FUTURE ONCOLOGY, 2022, 18 (33) : 3769 - 3782
  • [4] Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma
    Seo, Yeon Seok
    Kim, Jin Nam
    Keum, Bora
    Park, Sanghoon
    Kwon, Yong Dae
    Kim, Yong Sik
    Jeen, Yoon Tae
    Chun, Hoon Jai
    Kim, Chul Yong
    Kim, Chang Duck
    Ryu, Ho Sang
    Um, Soon Ho
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (15) : 2394 - 2400
  • [5] Sorafenib in unresectable hepatocellular carcinoma and advanced liver cirrhosis
    Pinter, M.
    Sieghart, W.
    Graziadei, I.
    Vogel, W.
    Koenigsberg, R.
    Weissmann, A.
    Kornek, G.
    Peck-Radosavljevic, M.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S13 - S13
  • [6] Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma
    Yeon Seok Seo
    Jin Nam Kim
    Bora Keum
    Sanghoon Park
    Yong Dae Kwon
    Yong Sik Kim
    Yoon Tae Jeen
    Hoon Jai Chun
    Chul Yong Kim
    Chang Duck Kim
    Ho Sang Ryu
    Soon Ho Um
    [J]. World Journal of Gastroenterology, 2008, (15) : 2394 - 2400
  • [7] A new chemotherapeutic regimen for advanced unresectable hepatocellular carcinoma
    Seki, S
    Yamada, T
    Kawakita, N
    Masuichi, H
    Kitada, T
    Sakaguchi, H
    [J]. HEPATO-GASTROENTEROLOGY, 2003, 50 (53) : 1598 - 1602
  • [8] Atezolizumab plus bevacizumab for advanced, unresectable hepatocellular carcinoma
    Tsilimigras, Diamantis I.
    Moris, Dimitrios
    [J]. JOURNAL OF BUON, 2021, 26 (02): : 637 - 638
  • [9] Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma
    Jaeger, HJ
    Mehring, UM
    Castaneda, F
    Hasse, F
    Blumhardt, G
    Loehlein, D
    Mathias, KD
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1996, 19 (06) : 388 - 396
  • [10] Outcomes of transarterial chemoembolisation for the treatment of advanced unresectable hepatocellular carcinoma
    Efthymiou, M.
    Roberts, S.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A248 - A248
12345